Nice call, I should have listened....if
they can be at $8, then PSTI should be at $80 ??
Do you have any others trading under $3 that you like?
Our time will come soon, very soon
this is part of article from SA in Dec, 2016.....
Pluristem Therapeutics (NASDAQ:PSTI) has popped up on a couple of my watch lists (I'll explain why in a moment) over the past year. The company just released information that is worth taking some time to understand.
President Obama just signed into law the 21st Century Cures Act, which is widely expected to speed up drug development by accelerating the regulatory approval process. The bill passed overwhelmingly in both the House of Representatives and the Senate but it did have two high-profile opponents in Elizabeth Warren and Bernie Sanders. These two big name Democrats believe that the bill is too favorable for pharmaceutical and biotech companies (NASDAQ:IBB).
The passage of this bill could be especially important for Pluristem. Its cell therapies PLX-R18 and PLX-PAD are likely to meet the criteria defined in the act as advanced regenerative therapies that can treat a wide range of disease. That would mean that the development time for these therapies may have just been accelerated in a major way.
There is no guarantee that will come to pass, of course, but a very encouraging sign is that Pluristem's program for CLI has been previously selected for a similar rapid pathway program in both Japan and Europe.
News 
Market Data 
Discover 
